What does Contipharma do?
CONTIPHARMA is a pharmaceutical company specializing in the development and production of generic medications. The company focuses on providing high-quality, affordable healthcare solutions to meet the needs of patients and healthcare providers. With a commitment to innovation and compliance, CONTIPHARMA ensures that its products meet rigorous industry standards.
- Signals
-
ProfitableProfitable € 1.07M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.23MStrong equity provides a buffer against setbacks.
Low riskLow risk 44.9%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.31A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.08MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 2.57MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 16.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
2.68M
|
€
-96K
|
€
-47K
|
€
-39K
|
|
|
€
2.57M
|
€
-175K
|
€
-131K
|
€
-107K
|
|
|
€
1.07M
|
€
-152K
|
€
-114K
|
€
-131K
|
|
|
€
3.23M
|
€
2.17M
|
€
2.32M
|
€
2.43M
|
|
|
44.85%
|
30.17%
|
41.8%
|
45.79%
|
|
|
€
3.98M
|
€
5.02M
|
€
3.23M
|
€
2.88M
|
|
|
€
706K
|
€
611K
|
€
67K
|
€
41K
|
|
|
2.00
|
1.00
|
1.00
|
1.00
|
Publications 25
All publications- Denomination - Objet - Demissions, Nominations - Statuts (Traduction, Coordination, Autres Modifications, ) 28/06/2021
- Demissions, Nominations 14/07/2017
- Me. - Comptes Annuels 31.12.2015, App 14.06.2016, Dpt 17.06.2016 16191-0462-013 23/06/2016
- Me. - Comptes Annuels 31.12.2014, App 09.06.2015, Dpt 28.08.2015 15521-0360-013 02/09/2015
- Me. - Comptes Annuels 31.12.2013, App 10.06.2014, Dpt 11.07.2014 14298-0169-013 15/07/2014
Frequently asked questions
Answers to the most common questions about Contipharma, based on official government data and the filed annual accounts.
What is the VAT number of Contipharma?
The VAT number of Contipharma is BE0466.820.220.
How many employees work at Contipharma?
In 2025, Contipharma employed 2.00 full-time equivalents (FTE).
When was Contipharma established?
Contipharma was founded in 09-09-1999.
What is the official address of Contipharma?
The official address of Contipharma is Rue De L'environnement 22 Seraing 4100.
What is the legal form of Contipharma?
The juridical form of Contipharma is Public limited company (NV/SA).
What is the annual revenue of Contipharma?
The 2025 accounts of Contipharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Contipharma do?
CONTIPHARMA is a pharmaceutical company specializing in the development and production of generic medications. The company focuses on providing high-quality, affordable healthcare solutions to meet the needs of patients and healthcare providers. With a commitment to innovation and compliance, CONTIPHARMA ensures that its products meet rigorous industry standards.
Is Contipharma a reliable company?
Contipharma is a registered Rechtspersoon with company number 0466.820.220 and can be verified through the official CBE database.
What is the credit limit of Contipharma?
The estimated credit limit of Contipharma is €2,842,095.
Is Contipharma still active?
Contipharma currently has the status "Normal situation" and is active.